ODAC Committee Votes to License Sandoz’s Zarxio®

Published date09 January 2015
Law FirmK&L Gates LLP
AuthorChristopher Betti,Jennifer Dienes,Maria Doukas,Margaux Nair
Subject MatterAmgen,Biosimilars,BPCIA,FDA,Pharmaceutical,Prescription Drugs,Public Health Service Act,Sandoz

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT